Tilray Brands Inc
TLRY: XTSE (CAN)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
CAD 2.30 | Hfx | Lrpjyzpg |
No-Moat Tilray Remains Profitable in Fragmented Canadian Market, Despite Competitive Pressures
Business Strategy and Outlook
Tilray cultivates and sells cannabis in Canada and exports into the global medical market. It also sells CBD products in the United States. The company is the result of legacy Aphria acquiring legacy Tilray in a reverse merger and renaming itself Tilray in 2021.